~~<i id='0483F4462D'><strike id='0483F4462D'><tt id='0483F4462D'><pre id='0483F4462D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：Wikipedia 2025-10-02 21:07:08 - browse：85

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Why we need to separate burnout from moral injury in health care

hotspot

Wikipedia

leisure time

focus

hotspot

Partofa"freezerfarm,"afootballfield-sizedfacilityforstoringfinishedCovid-19vaccines,underconstructio

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

Gene therapy has helped boys walk. Can scientists keep it that way?

The story of mRNA: From a loose idea to a tool that may help curb Covid

Patients, digital health players weigh in on FTC's data privacy plan

Illinois Supreme Court finds assault weapons ban constitutional

STAT's guide to the next generation of CAR

explore

leisure time

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Hollywood unions extend contract negotiations for actors

Megan Rapinoe shares emotional post following US Women's World Cup exit

Supreme Court strikes down use of affirmative action

Ask STAT: What do you want to know about ChatGPT in medicine?

How to save PrEP access — and even expand it

Gene therapy has helped boys walk. Can scientists keep it that way?

In age of alternative facts, a scholarly course on calling out crap

Colonoscopy at 40? Study finds a possible benefit

Wikipedia

Bird flu researchers hone in on Finland’s mink farms

New guidelines on severe brain injury complicate already difficult decisions

Patients, digital health players weigh in on FTC's data privacy plan

What to know about the judge who will handle the Trump case

#NeedHerScience: shining a light on gender disparities in medicine

The strategy behind pharma's lawsuits over drug pricing reform

leisure time

focus

hotspot

hotspot